JP2004536558A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004536558A5 JP2004536558A5 JP2002545129A JP2002545129A JP2004536558A5 JP 2004536558 A5 JP2004536558 A5 JP 2004536558A5 JP 2002545129 A JP2002545129 A JP 2002545129A JP 2002545129 A JP2002545129 A JP 2002545129A JP 2004536558 A5 JP2004536558 A5 JP 2004536558A5
- Authority
- JP
- Japan
- Prior art keywords
- src
- antisense compound
- expression
- human
- inhibiting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims 6
- 230000000692 anti-sense effect Effects 0.000 claims 5
- GYRJMKLTOVDJSG-MELONOIFSA-N (3s,3as,5as,7r,9s,9as,9bs)-7-bromo-3,5a,9-trimethyl-3a,4,5,6,7,9,9a,9b-octahydro-3h-benzo[g][1]benzofuran-2,8-dione Chemical compound C([C@]1(C)CC2)[C@@H](Br)C(=O)[C@@H](C)[C@@H]1[C@@H]1[C@@H]2[C@H](C)C(=O)O1 GYRJMKLTOVDJSG-MELONOIFSA-N 0.000 claims 4
- 101000974360 Mus musculus Nuclear receptor coactivator 2 Proteins 0.000 claims 4
- 230000002401 inhibitory effect Effects 0.000 claims 3
- 101000602930 Homo sapiens Nuclear receptor coactivator 2 Proteins 0.000 claims 2
- 102000055185 human NCOA2 Human genes 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 239000000074 antisense oligonucleotide Substances 0.000 claims 1
- 238000012230 antisense oligonucleotides Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
Claims (5)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72353000A | 2000-11-27 | 2000-11-27 | |
PCT/US2001/044220 WO2002042423A2 (en) | 2000-11-27 | 2001-11-26 | Antisense modulation of src-2 expression |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2004536558A JP2004536558A (en) | 2004-12-09 |
JP2004536558A5 true JP2004536558A5 (en) | 2005-05-19 |
Family
ID=24906651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002545129A Withdrawn JP2004536558A (en) | 2000-11-27 | 2001-11-26 | Antisense modulation of SRC-2 expression |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1343913A2 (en) |
JP (1) | JP2004536558A (en) |
AU (1) | AU2002237678A1 (en) |
WO (1) | WO2002042423A2 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8142198A (en) * | 1997-06-12 | 1998-12-30 | Regents Of The University Of California, The | A transcription factor coactivator protein, p/cip |
-
2001
- 2001-11-26 JP JP2002545129A patent/JP2004536558A/en not_active Withdrawn
- 2001-11-26 AU AU2002237678A patent/AU2002237678A1/en not_active Abandoned
- 2001-11-26 WO PCT/US2001/044220 patent/WO2002042423A2/en not_active Application Discontinuation
- 2001-11-26 EP EP01986485A patent/EP1343913A2/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2520541A1 (en) | Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field | |
JP2003503454A5 (en) | ||
JP2009513604A5 (en) | ||
JP2004509619A5 (en) | ||
JP2008513510A5 (en) | ||
JP2009508527A5 (en) | ||
JP2009500045A5 (en) | ||
JP2004534850A5 (en) | ||
CO6241169A2 (en) | METHODS FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA | |
WO2007031319A8 (en) | Compositions comprising immunostimulatory rna oligonucleotides and methods for producing said rna oligonucleotides | |
JP2007504269A5 (en) | ||
EP2251007A3 (en) | Sphingosine-1-phosphate (S1P) receptor agonists for use in the treatment of demyelinating diseases | |
JP2002541233A5 (en) | ||
JP2011528713A5 (en) | ||
WO2007122580A3 (en) | Compositions of phenylephrine useful for treatment of respiratory illness | |
FI3782612T3 (en) | Oral formulations of cytidine analogs and methods of use thereof | |
JP2008528761A5 (en) | ||
JP2005237328A5 (en) | ||
JP2010500284A5 (en) | ||
WO2003101394A3 (en) | Defensins: use as antiviral agents | |
JP2008521927A5 (en) | ||
JP2004503232A5 (en) | ||
WO2010008474A3 (en) | Methods for treating multiple sclerosis using antisense oligonucleotides | |
JP2009511426A5 (en) | ||
JP2010537958A5 (en) |